Related Experiment Video
Updated: Jan 28, 2026

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
FGF2-FGFR1 pathway activation together with thymidylate synthase upregulation is induced in pemetrexed-resistant lung
Kentaro Miura1, Takaaki Oba1, Kazutoshi Hamanaka1
1Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, Japan.
Abstract:
Pemetrexed (MTA) is a folate antimetabolite used for treating non-small cell lung cancer. To elucidate the mechanisms of pemetrexed resistance in lung cancer, we established pemetrexed-resistant sublines in PC9 (mutant EGFR) and H1993 (wild-type EGFR) lung adenocarcinoma cell lines (PC9-MTA, H1993-MTA). Gene expression profile comparison by microarray analyses revealed enhanced fibroblast growth factor 2 (FGF2) and FGF receptor 1 (FGFR1) expression, confirmed by Western blotting, enzyme-linked immunosorbent assay, and reverse transcription-polymerase chain reaction. ERK phosphorylation was increased in PC9-MTA but decreased in H1993-MTA along with decreased downstream signaling molecule phosphorylation. Cellular morphological change from epithelial to spindle-shape together with increased mesenchymal marker protein expression was observed in H1993-MTA. SiRNA-mediated FGF2 knockdown partially restored pemetrexed sensitivity in both lines, whereas anti-FGFR1 inhibitor PD173074 restored pemetrexed sensitivity in PC9-MTA. FGF2 or FGFR1 inhibition decreased pERK levels in PC9-MTA but increased pEGFR levels together with downstream signaling molecule activation and reversed epithelial-mesenchymal transition marker protein expression in H1993-MTA. Although thymidylate synthase strongly facilitates the development of pemetrexed resistance, our results reveal involvement of the FGF2-FGFR1 pathway in pemetrexed resistance in lung cancer cells and suggest that cellular function alterations induced by FGF2-FGFR1 pathway activation depend on the innate feature of cancer cells.
Insights
This study reveals the fibroblast growth factor 2 (FGF2) and FGF receptor 1 (FGFR1) pathway contributes to pemetrexed resistance in non-small cell lung cancer. Inhibiting this pathway can restore sensitivity, highlighting a potential therapeutic target.
Area of Science:
- Molecular Biology
- Oncology
- Cancer Research
Background:
- Pemetrexed (MTA) is a key antifolate drug for non-small cell lung cancer (NSCLC).
- Mechanisms of pemetrexed resistance in NSCLC remain incompletely understood.
- Understanding resistance is crucial for improving treatment efficacy.
Purpose of the Study:
- To investigate the molecular mechanisms underlying pemetrexed resistance in NSCLC.
- To identify novel pathways involved in pemetrexed resistance.
- To explore potential therapeutic strategies targeting these pathways.
Main Methods:
- Establishment of pemetrexed-resistant NSCLC cell lines (PC9-MTA, H1993-MTA).
- Microarray analysis for gene expression profiling.
- Confirmation of gene and protein expression using Western blotting, ELISA, and RT-PCR.
- Functional studies involving siRNA-mediated knockdown and pharmacological inhibition (PD173074).
Main Results:
- Enhanced expression of fibroblast growth factor 2 (FGF2) and FGF receptor 1 (FGFR1) was observed in resistant cell lines.
- FGF2/FGFR1 inhibition partially restored pemetrexed sensitivity.
- Specific effects on ERK phosphorylation and epithelial-mesenchymal transition (EMT) markers were cell-line dependent.
- FGF2/FGFR1 pathway activation influences cell-specific alterations contributing to resistance.
Conclusions:
- The FGF2-FGFR1 signaling pathway plays a significant role in mediating pemetrexed resistance in NSCLC.
- Targeting the FGF2-FGFR1 pathway presents a potential strategy to overcome pemetrexed resistance.
- The impact of FGF2-FGFR1 pathway activation on resistance mechanisms is influenced by intrinsic cancer cell characteristics.
Related Concept Videos
Treatment Resistant Cancers
ATP Synthase: Mechanism
ATP Synthase: Structure
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Mechanisms of Retrovirus-induced Cancers
Lung Capacity

